Reference
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Releases Evidence Report on Disease-Modifying Therapies for Multiple Sclerosis, including Daclizumab and Ocrelizumab. Internet Document : 26 Jan 2017. Available from: URL: https://icer-review.org/announcements/ms-evidence-report/
Rights and permissions
About this article
Cite this article
ICER publishes report on disease-modifying MS treatments. PharmacoEcon Outcomes News 771, 4 (2017). https://doi.org/10.1007/s40274-017-3715-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-3715-3